vs

Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and RENASANT CORP (RNST). Click either name above to swap in a different company.

RENASANT CORP is the larger business by last-quarter revenue ($273.8M vs $269.1M, roughly 1.0× Inspire Medical Systems, Inc.). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs 32.2%, a 18.4% gap on every dollar of revenue. Over the past eight quarters, RENASANT CORP's revenue compounded faster (29.3% CAGR vs 28.1%).

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

Renasant Bank is an American regional commercial financial institution based in Tupelo, Mississippi. The bank has more than 280 branches in Alabama, Florida, Georgia, Mississippi, Louisiana, Tennessee, North Carolina and South Carolina. Renasant Bank operates under the parent company Renasant Corporation and is affiliated with Renasant Nation, a platform through which they publish blogs and shows.

INSP vs RNST — Head-to-Head

Bigger by revenue
RNST
RNST
1.0× larger
RNST
$273.8M
$269.1M
INSP
Higher net margin
INSP
INSP
18.4% more per $
INSP
50.6%
32.2%
RNST
Faster 2-yr revenue CAGR
RNST
RNST
Annualised
RNST
29.3%
28.1%
INSP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INSP
INSP
RNST
RNST
Revenue
$269.1M
$273.8M
Net Profit
$136.1M
$88.2M
Gross Margin
86.6%
Operating Margin
17.1%
Net Margin
50.6%
32.2%
Revenue YoY
12.2%
Net Profit YoY
286.4%
112.5%
EPS (diluted)
$4.57
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSP
INSP
RNST
RNST
Q1 26
$273.8M
Q4 25
$269.1M
$278.4M
Q3 25
$224.5M
$269.5M
Q2 25
$217.1M
$267.2M
Q1 25
$201.3M
$170.7M
Q4 24
$239.7M
$167.1M
Q3 24
$203.2M
$220.3M
Q2 24
$195.9M
$163.8M
Net Profit
INSP
INSP
RNST
RNST
Q1 26
$88.2M
Q4 25
$136.1M
$78.9M
Q3 25
$9.9M
$59.8M
Q2 25
$-3.6M
$1.0M
Q1 25
$3.0M
$41.5M
Q4 24
$35.2M
$44.7M
Q3 24
$18.5M
$72.5M
Q2 24
$9.8M
$38.8M
Gross Margin
INSP
INSP
RNST
RNST
Q1 26
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Operating Margin
INSP
INSP
RNST
RNST
Q1 26
Q4 25
17.1%
34.8%
Q3 25
4.3%
27.9%
Q2 25
-1.5%
1.0%
Q1 25
-0.7%
30.4%
Q4 24
13.3%
29.8%
Q3 24
7.0%
44.2%
Q2 24
2.6%
29.6%
Net Margin
INSP
INSP
RNST
RNST
Q1 26
32.2%
Q4 25
50.6%
28.4%
Q3 25
4.4%
22.2%
Q2 25
-1.7%
0.4%
Q1 25
1.5%
24.3%
Q4 24
14.7%
26.8%
Q3 24
9.1%
32.9%
Q2 24
5.0%
23.7%
EPS (diluted)
INSP
INSP
RNST
RNST
Q1 26
$0.94
Q4 25
$4.57
$0.78
Q3 25
$0.34
$0.63
Q2 25
$-0.12
$0.01
Q1 25
$0.10
$0.65
Q4 24
$1.17
$0.70
Q3 24
$0.60
$1.18
Q2 24
$0.32
$0.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSP
INSP
RNST
RNST
Cash + ST InvestmentsLiquidity on hand
$308.3M
$1.2B
Total DebtLower is stronger
$806.2M
Stockholders' EquityBook value
$781.2M
$3.9B
Total Assets
$907.3M
$27.1B
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSP
INSP
RNST
RNST
Q1 26
$1.2B
Q4 25
$308.3M
$1.1B
Q3 25
$322.6M
$1.1B
Q2 25
$300.9M
$1.4B
Q1 25
$369.2M
$1.1B
Q4 24
$445.5M
$1.1B
Q3 24
$411.0M
$1.3B
Q2 24
$439.7M
$851.9M
Total Debt
INSP
INSP
RNST
RNST
Q1 26
$806.2M
Q4 25
$499.8M
Q3 25
$558.9M
Q2 25
$557.0M
Q1 25
$433.3M
Q4 24
$430.6M
Q3 24
$433.2M
Q2 24
$428.7M
Stockholders' Equity
INSP
INSP
RNST
RNST
Q1 26
$3.9B
Q4 25
$781.2M
$3.9B
Q3 25
$666.5M
$3.8B
Q2 25
$677.8M
$3.8B
Q1 25
$635.7M
$2.7B
Q4 24
$689.7M
$2.7B
Q3 24
$696.6M
$2.7B
Q2 24
$638.1M
$2.4B
Total Assets
INSP
INSP
RNST
RNST
Q1 26
$27.1B
Q4 25
$907.3M
$26.8B
Q3 25
$807.7M
$26.7B
Q2 25
$802.2M
$26.6B
Q1 25
$730.8M
$18.3B
Q4 24
$808.4M
$18.0B
Q3 24
$796.2M
$18.0B
Q2 24
$728.4M
$17.5B
Debt / Equity
INSP
INSP
RNST
RNST
Q1 26
0.21×
Q4 25
0.13×
Q3 25
0.15×
Q2 25
0.15×
Q1 25
0.16×
Q4 24
0.16×
Q3 24
0.16×
Q2 24
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSP
INSP
RNST
RNST
Operating Cash FlowLast quarter
$52.5M
Free Cash FlowOCF − Capex
$41.8M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$78.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSP
INSP
RNST
RNST
Q1 26
Q4 25
$52.5M
$271.5M
Q3 25
$68.5M
$135.5M
Q2 25
$2.7M
$-77.3M
Q1 25
$-6.7M
$106.2M
Q4 24
$69.2M
$106.4M
Q3 24
$52.3M
$-1.7M
Q2 24
$-78.0K
$-49.1M
Free Cash Flow
INSP
INSP
RNST
RNST
Q1 26
Q4 25
$41.8M
$237.8M
Q3 25
$58.1M
$120.1M
Q2 25
$-6.3M
$-87.5M
Q1 25
$-15.1M
$101.3M
Q4 24
$62.2M
$92.8M
Q3 24
$44.3M
$-5.3M
Q2 24
$-12.5M
$-52.6M
FCF Margin
INSP
INSP
RNST
RNST
Q1 26
Q4 25
15.5%
85.4%
Q3 25
25.9%
44.6%
Q2 25
-2.9%
-32.7%
Q1 25
-7.5%
59.4%
Q4 24
25.9%
55.5%
Q3 24
21.8%
-2.4%
Q2 24
-6.4%
-32.1%
Capex Intensity
INSP
INSP
RNST
RNST
Q1 26
Q4 25
4.0%
12.1%
Q3 25
4.6%
5.7%
Q2 25
4.1%
3.8%
Q1 25
4.2%
2.8%
Q4 24
2.9%
8.2%
Q3 24
3.9%
1.6%
Q2 24
6.3%
2.1%
Cash Conversion
INSP
INSP
RNST
RNST
Q1 26
Q4 25
0.39×
3.44×
Q3 25
6.90×
2.27×
Q2 25
-75.92×
Q1 25
-2.24×
2.56×
Q4 24
1.96×
2.38×
Q3 24
2.83×
-0.02×
Q2 24
-0.01×
-1.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INSP
INSP

Segment breakdown not available.

RNST
RNST

Net Interest Income$223.6M82%
Noninterest Income$50.3M18%

Related Comparisons